Single-dose pharmacokinetics and penetration of BMS 284756 into an inflammatory exudate

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 1, 2002, Pages 242-244

  Wise, R ^a   Gee, T ^a   Marshall, G ^a   Andrews, J M ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANTHARIDIN; GARENOXACIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PENETRATION; EXUDATE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL;

ADULT; ANTI-INFECTIVE AGENTS; CANTHARIDIN; FLUOROQUINOLONES; HUMANS; INDOLES; INFLAMMATION; MALE; METABOLIC CLEARANCE RATE; QUINOLONES;

EID: 0036136180     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.1.242-244.2002     Document Type: Article

References (6)

1. Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756
2. Pharmacodynamics of the fluoroquinolones
3. In vitro and in vivo activities of T3811ME, a novel des-F-(6)-quinolone
4. A study to determine the pharmacokinetics and inflammatory fluid penetration of gatifloxacin following a single oral dose
5. The influence of protein binding upon tissue fluid levels of six β-lactam antibiotics
6. Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP99,219)